APRE
Aprea Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.44 / 10
Netural
The security demonstrates poor fundamental health (3.4/10). Positive indicators: Inventory turnover ratio and Interest coverage ratio (EBIT / Interest expense) (%), offset by weaknesses in Total operating revenue (YoY growth rate %) and Operating revenue (YoY growth rate %). Analytical conclusion: constrained.
Analysis Checks(6/10)
Revenue-MV
Value-7.12
Score1/3
Weight9.37%
1M Return3.98%
Value-7.12
Score1/3
Weight9.37%
1M Return3.98%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.26%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.26%
1M Return-1.23%
PB-ROE
Value-0.49
Score1/3
Weight22.01%
1M Return8.79%
Value-0.49
Score1/3
Weight22.01%
1M Return8.79%
Operating revenue (YoY growth rate %)
Value-78.22
Score1/3
Weight-0.99%
1M Return-0.52%
Value-78.22
Score1/3
Weight-0.99%
1M Return-0.52%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.85%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.85%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value-78.22
Score1/3
Weight-1.14%
1M Return-0.60%
Value-78.22
Score1/3
Weight-1.14%
1M Return-0.60%
Profit-MV
Value0.47
Score2/3
Weight21.77%
1M Return8.99%
Value0.47
Score2/3
Weight21.77%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.35%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.35%
1M Return-1.25%
Asset-MV
Value-0.51
Score3/3
Weight34.53%
1M Return11.94%
Value-0.51
Score3/3
Weight34.53%
1M Return11.94%
Cash-MV
Value-0.07
Score2/3
Weight20.89%
1M Return8.80%
Value-0.07
Score2/3
Weight20.89%
1M Return8.80%
Revenue-MV
Value-7.12
Score1/3
Weight9.37%
1M Return3.98%
Value-7.12
Score1/3
Weight9.37%
1M Return3.98%
Total operating revenue (YoY growth rate %)
Value-78.22
Score1/3
Weight-1.14%
1M Return-0.60%
Value-78.22
Score1/3
Weight-1.14%
1M Return-0.60%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.26%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.26%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight21.77%
1M Return8.99%
Value0.47
Score2/3
Weight21.77%
1M Return8.99%
PB-ROE
Value-0.49
Score1/3
Weight22.01%
1M Return8.79%
Value-0.49
Score1/3
Weight22.01%
1M Return8.79%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.35%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.35%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value-78.22
Score1/3
Weight-0.99%
1M Return-0.52%
Value-78.22
Score1/3
Weight-0.99%
1M Return-0.52%
Asset-MV
Value-0.51
Score3/3
Weight34.53%
1M Return11.94%
Value-0.51
Score3/3
Weight34.53%
1M Return11.94%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.85%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.85%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight20.89%
1M Return8.80%
Value-0.07
Score2/3
Weight20.89%
1M Return8.80%
Is APRE fundamentally strong?
- APRE scores 3.44/10 on fundamentals and holds a Fair valuation at present. Backed by its -62.89% ROE, -2670.56% net margin, -0.30 P/E ratio, 0.34 P/B ratio, and 24.29% earnings growth, these metrics solidify its Netural investment rating.
